Oculis Holding AG

OCSAW chart

Oculis Holding AG news

• Oculis to Host In-Person and Virtual R&D Day: Advancing a Differentiated Late-Stage Development Pipeline

  Yahoo Finance · Nov 9, 2:00 AM EST

• Down 21.1% in 4 Weeks, Here's Why Oculis Holding AG (OCS) Looks Ripe for a Turnaround

  Yahoo Finance · Nov 6, 8:35 AM EST

• Oculis Holding AG (OCS) Reports Q3 Loss, Lags Revenue Estimates

  Yahoo Finance · Nov 3, 6:55 PM EST

• Oculis Reports Q3 2026 Financial Results and Builds Momentum Toward Multiple Upcoming Pipeline Catalysts

  Yahoo Finance · Nov 3, 4:05 PM EST

• Oculis Holding AG (OCS) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

  Yahoo Finance · Nov 2, 9:00 AM EST

• Oculis Appoints Experienced Life Sciences Leader Björn Tackenberg, M.D., Ph.D., as Chief Scientific Officer to Advance Neurology Innovation

  Yahoo Finance · Nov 2, 3:18 AM EST

• Oculis to Feature Privosegtor’s Neuroprotective Potential and Ongoing PIONEER Program at APOIS Congress and CNS Summit

  Yahoo Finance · Oct 29, 5:39 AM EDT

• Oculis Reports New Phase 2 ACUITY Biomarker Data  Further Supporting Privosegtor’s Neuroprotective Potential in Optic Neuritis

  Yahoo Finance · Oct 22, 2:00 AM EDT

• Oculis to Present Late-Breaking Phase 2 ACUITY Biomarker Analyses of Privosegtor in Optic Neuritis at the 10th Joint ACTRIMS-ECTRIMS Meeting

  Yahoo Finance · Oct 20, 2:00 AM EDT

• Oculis lýkur slembiröðun í PREDICT-1 skráningarrannsókninni á Licaminlimab við TNFR1-miðluðum augnþurrki

  Yahoo Finance · Oct 19, 2:00 AM EDT

• Oculis Completes Randomization in PREDICT-1 Registrational Trial of Licaminlimab for TNFR1-Mediated Dry Eye Disease

  Yahoo Finance · Oct 19, 2:00 AM EDT

• Oculis to Highlight Licaminlimab at Eyecelerator @ AAO 2026 and Partner with Neuro-Ophthalmology Subspecialty Day

  Yahoo Finance · Oct 7, 2:00 AM EDT

Oculis Holding AG key financials

No XBRL financial data is available for this company yet.

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

• 6-K6-K2026-11-03
• 6-K6-K2026-09-30
• 6-K6-K2026-08-10
• 6-K6-K2026-08-06
• 6-K6-K2026-06-25
• 6-K6-K2026-06-01
• 6-K6-K2026-05-14
• 6-K6-K2026-05-11
• 6-K6-K2026-04-21
• 6-K6-K2026-03-04
• 20-F20-F2026-03-04
• 6-K6-K2026-03-03

About Oculis Holding AG

Ticker

OCSAW (Nasdaq)

Industry

Pharmaceutical Preparations

Headquarters

Zug, Switzerland

Incorporated in

Switzerland

Fiscal year end

December 31

SEC CIK

1953530

Frequently asked questions